IMCC
IM Cannabis Corp.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · IL
$1.50
+7.91%Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open$1.48
From 52W high−97.52%
Volume87619.00
Market cap$928348.50
P/E (TTM)—
P/S (TTM)0.0x
Div yield—
Key dataOct 19, 2026
Open
$1.48
From 52W high
−97.52%
Volume
87619.00
Market cap
$928348.50
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−1.6x
P/E (TTM)
—
RSI (14)
40.3
MomentumView details →
1D Return
+7.91%
YTD Return
−96.33%
SummaryUpdated Jun 1, 2026
IM Cannabis Corp. (NASDAQ:IMCC) is an Israeli-based medical cannabis company founded in 2016 that has evolved from a multi-market operator to a focused player in the German and Israeli medical cannabis markets. The company went public in May 2020 and is headquartered in Tel Aviv-Yafo, Israel. After initially expanding into Canada, IM Cannabis has strategically refocused its operations on the more promising European and Middle Eastern markets, particularly capitalizing on Germany's cannabis legalization in April 2024.
Similar companies
Latest newsMore news →
Ohio's Division of Cannabis Control investigated two serious adverse health events linked to products sold at Herbal Wellness Center in Jackson, Ohio, prompting the dispensary's voluntary closure on Sept. 1 and its reopening on Sept. 17 after tests found no contaminants.21d agoIM Cannabis Corp. entered into a letter of intent to sell its European-focused assets to Slil.com Holding Ltd.124d agoIM Cannabis Corp. filed a resale registration statement on Form F-3 with the SEC, registering 17,276,931 common shares for resale.132d ago